Back to search results

Comparing Cooler Devices for Donor Heart Transport

This study is comparing two ways to transport donor hearts for transplant: the Paragonix SherpaPak (a commercially available device) and an adjustable temperature RYOBI cooler. The RYOBI cooler aims to keep the heart at a precise temperature, reduce waste, and save costs. You might be able to join if you are an adult (18 or older) and are having a heart transplant only (not other organs). The main goal is to see if one method leads to fewer problems with the new heart (primary graft dysfunction) within 30 days after transplant. The study status is currently unclear.

Study design
This study will involve 80 participants. The method for storing the donor heart will be chosen randomly between two options.
What's involved
After your heart transplant, the research team will review your medical records for 30 days to collect information about your care.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 30 days after their heart transplant.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07354763

Precise Cooler for Donor Heart Transport

Not Yet Recruiting
NAAll AgesInterventional
Cedars-Sinai Medical Center
~80 participants
Updated 2026-03-18 on ClinicalTrials.gov
What's tested:Organ transport using SherpaPakRyobi cooler for Organ Transport

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of primary graft dysfunction
Measured over From Randomization to 30 days after heart transplantation

Conditions

Heart Transplantation

Explore related trials

Heart Failure

NCT07354763

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Cedars Sinai Medical Center

    Los Angeles, Californiastudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Dominic Emerson, MD
[email protected]
310-423-3300
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Individuals 18 years old or older are included.
Individuals undergoing isolated heart transplantation are included.

Exclusion

Any records flagged "break the glass" or "research opt out."
Any patients undergoing multi-organ transplantation.

What this trial measures

  • Incidence of primary graft dysfunctionFrom Randomization to 30 days after heart transplantation

    compare the incidence of primary graft dysfunction between patients randomized to donor heart preservation using the adjustable temperature RYOBI cooler (Model # Pi1824QBT) (n = 40) versus the Paragonix SherpaPak (n = 40) in cases where the anticipated total ischemic time for the graft is between 120 and 240 minutes.